OptiBiotix Health PLC (LON:OPTI) has launched its SlimBiome and LP products in the US at the Supply Side West trade show.
Both products recently received FDA registration and the presentation at Supply Side West was the first in a number of steps to attract food, beverage, consumer healthcare and pharmaceutical partners for distribution and sale into the US market.
Cholesterol reducer LP was co-exhibited with Sacco, one of the largest suppliers of probiotic ingredients, while appetite suppressant SlimBiome was co-exhibited with specialty ingredients manufacturer, Cereal Ingredients.
The event was attended by 16,500 ingredient buyers and suppliers from the supplement, beverage, functional food, personal care and sports nutrition industries with high interest from around the world, said the company.
Additionally, Optibiotix said that Sacco has appointed Dr Lucio Lepera as product manager for LP’s entry into the US probiotic market and extend it into the dairy market.
Cereal Ingredients, meanwhile, has incorporated SlimBiome into its range of cereal-based particulates and speciality ingredients that includes bakery products, breakfast cereals, crackers, toppings, products that extend it into the nutraceutical, health and wellbeing industry sectors.
Stephen O'Hara, OptiBiotix’s chief executive, said in a statement: "We are extremely pleased with the very high level of interest from both national and multinational companies interested in our products and the opportunity to meet with senior US and Asian decision makers at Supply Side West.
He added looking for partners was a low risk, low cost approach to accessing multiple consumer healthcare and pharmaceutical markets around the world with multiple products.